Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia

Published:2019-04-03 Issue:7 Volume:74 Page:2055-2059
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Shah Megan D¹,Coe Kelci E²,El Boghdadly Zeinab²,Wardlow Lynn C³,Dela-Pena Jennifer C⁴,Stevenson Kurt B²⁵,Reed Erica E³

Affiliation:

1. Department of Pharmacy, University of Virginia Health System, Charlottesville, VA, USA

2. Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA

3. Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA

4. Department of Pharmacy, Advocate Good Samaritan Hospital, Downers Grove, IL, USA

5. Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/7/2055/28851722/dkz116.pdf

Reference13 articles.

1. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen;Brooke;Clin Microbiol Rev,2012

2. Evaluation of trimethoprim/sulfamethoxazole (SXT), minocycline, tigecycline, moxifloxacin, and ceftazidime alone and in combinations for SXT-susceptible and SXT-resistant Stenotrophomonas maltophilia by in vitro time-kill experiments;Wei;PLoS One,2016

3. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations;Cho;BMC Infect Dis,2015

4. In vitro activities of antimicrobial combinations against Stenotrophomonas maltophilia;Poulos;Antimicrob Agents Chemother,1995

5. Activity of trimethoprim/sulfamethoxazole plus polymyxin B against multiresistant Stenotrophomonas maltophilia;Munoz;Eur J Clin Microbiol Infect Dis,1996

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Description, clinical impact and early outcome of S. maltophilia respiratory tract infections after lung transplantation, A retrospective observational study;Respiratory Medicine and Research;2024-11

2. Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice;Current Opinion in Infectious Diseases;2024-07-30

3. Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan;Journal of Antimicrobial Chemotherapy;2024-06-06

4. Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study;Expert Review of Anti-infective Therapy;2024-05-13

5. Clinical Outcomes of Trimethoprim/Sulfamethoxazole in Critically Ill Patients with Stenotrophomonas maltophilia Bacteremia and Pneumonia Utilizing Renal Replacement Therapies;Journal of Clinical Medicine;2024-04-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3